Certified by Founder Lodge
Lighthouse Pharmaceuticals
United States - San Francisco Bay Area
START UP
1 Disclosed Funding Rounds $12,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Lighthouse develops small-molecule therapeutics, leveraging translational insights and extensive clinical experience to address chronic degenerative and inflammatory disorders, with a lead cl
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 29 ,2026 | Series A | $12,000,000 |
Double Point Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Furientis | $5,000,000 | (May 19, 2026)
Arkeus | $18,000,000 | (May 19, 2026)
Shyld AI | $13,400,000 | (May 19, 2026)
Cimento AI | $3,000,000 | (May 19, 2026)
Cosmico | $12,000,000 | (May 19, 2026)
